Have an account? Log in.
I don't have an account.
https://endpoints.news/acting-fda-commissioner-pledges-to-prevent-political-interference-in-rare-disease-meeting/
US stocks up, Dow Jones up 171 pts. Replimune Group rises after FDA agreement. Other big gainers include Dell, NetApp, and Okta.
https://subscriber.politicopro.com/article/2026/05/makarys-time-atop-fda-over-tktk-named-acting-commissioner-00916014
https://www.cbsnews.com/news/trump-approves-plan-to-fire-fda-commissioner-marty-makary/?intcid=CNM-00-10abd1h
HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target from $70 to $50.
FDA Chief Marty Makary defends decisions amid backlash over drug rejections, internal turmoil and criticism from biotech firms and lawmakers.